Stock Events

Stock Events

Stoke Therapeutics (STOK) Q2 2025 Earnings

13MayConfirmed

Q3 2024

Q4 2024

Q1 2025

Q2 2025

-0.55

0.27

1.08

1.9

Details

Expected EPS

0.109

Actual EPS

1.9

Surprise EPS

1.79

Surprise Percent

+1,643.12%

Description

Stoke Therapeutics (STOK) has reported earnings of 1.9 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.